Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction

European Journal of Gastroenterology and Hepatology

Volumn 30, Issue 9, 2018, Pages 1047-1054

  Olubamwo, Olubunmi O ^a   Virtanen, Jyrki K ^a   Voutilainen, Ari ^a   Kauhanen, Jussi ^a   Pihlajamäki, Jussi ^a,b   Tuomainen, Tomi Pekka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

acute myocardial infarction; atherogenic; cardiovascular disease; fatty liver disease; fatty liver index; Kuopio ischaemic heart disease risk factor study; metabolic factors; predictor

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE ASSOCIATION; FATTY LIVER INDEX; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; ALGORITHM; DECISION SUPPORT SYSTEM; FINLAND; HEART INFARCTION; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; NONALCOHOLIC FATTY LIVER; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR;

ADULT; ALGORITHMS; CARDIOVASCULAR DISEASES; DECISION SUPPORT TECHNIQUES; FINLAND; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NON-ALCOHOLIC FATTY LIVER DISEASE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 85051126092     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000001183     Document Type: Article

References (35)

1. World Health Organization. Cardiovascular diseases fact sheet; 2017. Available at: http://www.who.int/news-room/fact-sheets/detail/cardio vascular-diseases-(cvds). [Accessed 17 July 2017].
2. Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med 2017; 376:2053-2064.
3. Wang TJ. New cardiovascular risk factors exist, but are they clinically useful? Eur Heart J 2008; 29:441-444.
4. deGoma EM, Knowles JW, Angeli F, Budoff MJ, Rader DJ. The evolution and refinement of traditional risk factors for cardiovascular disease. Cardiol Rev 2012; 20:118-129.
5. Perseghin G. The role of non-alcoholic fatty liver disease in cardiovascular disease. Dig Dis 2010; 28:210-213.
6. Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A, et al. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis 2013; 230:258-267.
7. Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 2012; 33:1190-1200.
8. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191:235-240.
9. Pisto P, Santaniemi M, Bloigu R, Ukkola O, Kesaniemi YA. Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open 2014; 4:e004973.
10. Perazzo H, Poynard T, Dufour J. The interactions of nonalcoholic fatty liver disease and cardiovascular diseases. Clin Liver Dis 2014; 18:233-248.
11. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6:33.
12. Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol 2013; 11:1201-1204.
13. Kahl S, Straßburger K, Nowotny B, Livingstone R, Kluppelholz B, Keßel K. Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance. PloS One 2014; 9:e94059.
14. Fedchuk L, Nascimbeni F, Pais R, Charlotte F, Housset C, Ratziu V. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2014; 40:1209-1222.
15. Pais R, Giral P, Khan J, Rosenbaum D, Housset C, Poynard T, et al. Fatty liver is an independent predictor of early carotid atherosclerosis. J Hepatol 2016; 65:95-102.
16. Gastaldelli A, Kozakova M, Hojlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009; 49:1537-1544.
17. Kozakova M, Palombo C, Paterni Eng M, Dekker J, Flyvbjerg A, Mitrakou A, et al. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology 2012; 55:1406-1415.
18. Kunutsor SK, Bakker SJ, Blokzijl H, Dullaart RP. Associations of the fatty liver and hepatic steatosis indices with risk of cardiovascular disease: Interrelationship with age. Clinica Chimica Acta 2017; 466:54-60.
19. Kaplan GA, Wilson TW, Cohen RD, Kauhanen J, Wu M, Salonen JT. Social functioning and overall mortality: prospective evidence from the Kuopio Ischemic Heart Disease Risk Factor Study. Epidemiology 1994; 5:495-500.
20. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 1988; 20:46-50.
21. Salonen JT, Salonen R, Seppanen K, Rauramaa R, Tuomilehto J. HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation 1991; 84:129-139.
22. Rasanen J, Kauhanen J, Lakka T, Kaplan GA, Salonen JT. Religious affiliation and all-cause mortality: a prospective population study in middle-aged men in eastern Finland. Int J Epidemiol 1996; 25:1244-1249.
23. Willenbring ML, Massey SH, Gardner MB. Helping patients who drink too much: an evidence-based guide for primary care physicians. Am Fam Physician 2009; 80:44-50.
24. McGuire S. U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011. Adv Nutr 2011; 2:293-294.
25. Fawehinmi TO, Ilomäki J, Voutilainen S, Kauhanen J. Alcohol consumption and dietary patterns: the FinDrink study. PLoS One 2012; 7:e38607.
26. Virtanen JK, Mursu J, Tuomainen TP, Voutilainen S. Dietary fatty acids and risk of coronary heart disease in men: the Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler Thromb Vasc Biol 2014; 34:2679-2687.
27. Jiang Z, Xu C, Chang X, Li W, Sun L, Yang X, Yu L. Fatty liver index correlates with non-alcoholic fatty liver disease, but not with newly diagnosed coronary artery atherosclerotic disease in Chinese patients. BMC Gastroenterol 2013; 13:110.
28. Onat A, Can G, Kaya A, Akbas T, Ozpamuk-Karadeniz F, Simsek B, et al. Fatty liver disease: disparate predictive ability for cardiometabolic risk and all-cause mortality. World J Gastroenterol 2015; 21:13555-13565.
29. Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, Arcaro G. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007; 30:2119-2121.
30. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363:1341-1350.
31. Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol 2014; 28:637-653.
32. Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009; 42:1331-1346.
33. Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008; 51:1947-1953.
34. Than NN, Newsome PN. A concise review of non-alcoholic fatty liver disease. Atherosclerosis 2015; 239:192-202.
35. Puchner SB, Lu MT, Mayrhofer T, Liu T, Pursnani A, Ghoshhajra BB, et al. High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial. Radiology 2014; 274:693-701.